DK3197556T3 - Sammensætning til forebyggelse og/eller behandling af allergisymptomer - Google Patents
Sammensætning til forebyggelse og/eller behandling af allergisymptomer Download PDFInfo
- Publication number
- DK3197556T3 DK3197556T3 DK15791737.8T DK15791737T DK3197556T3 DK 3197556 T3 DK3197556 T3 DK 3197556T3 DK 15791737 T DK15791737 T DK 15791737T DK 3197556 T3 DK3197556 T3 DK 3197556T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- composition
- allergy symptoms
- allergy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20141641 | 2014-09-22 | ||
PCT/IB2015/057267 WO2016046728A1 (en) | 2014-09-22 | 2015-09-21 | Composition for the prevention and/or treatment of allergy symptoms |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3197556T3 true DK3197556T3 (da) | 2024-01-22 |
Family
ID=51799187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15791737.8T DK3197556T3 (da) | 2014-09-22 | 2015-09-21 | Sammensætning til forebyggelse og/eller behandling af allergisymptomer |
Country Status (14)
Country | Link |
---|---|
US (2) | US10143715B2 (da) |
EP (1) | EP3197556B1 (da) |
CA (1) | CA2958174C (da) |
DK (1) | DK3197556T3 (da) |
ES (1) | ES2968372T3 (da) |
FI (1) | FI3197556T3 (da) |
HR (1) | HRP20240090T1 (da) |
MX (1) | MX2017003360A (da) |
PL (1) | PL3197556T3 (da) |
PT (1) | PT3197556T (da) |
RS (1) | RS65173B1 (da) |
SI (1) | SI3197556T1 (da) |
SM (1) | SMT202400084T1 (da) |
WO (1) | WO2016046728A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107660794A (zh) * | 2017-08-31 | 2018-02-06 | 王双亮 | 一种药食同源槐米的制备方法 |
IT202100021659A1 (it) * | 2021-08-10 | 2023-02-10 | A&R Pharma Srl | Composizione topica e suo uso per il trattamento nasale della rinite |
IT202200002108A1 (it) * | 2022-02-07 | 2023-08-07 | Indena Spa | Composizioni a base di quercetina per il trattamento e la prevenzione di affezioni oculari |
US20230338274A1 (en) * | 2022-04-22 | 2023-10-26 | Dermacisen, S.A. | Food supplement for hair care and hair loss prevention. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001114686A (ja) | 1999-10-15 | 2001-04-24 | Sunstar Inc | Th2サイトカイン発現抑制剤 |
IT1315252B1 (it) | 1999-10-21 | 2003-02-03 | Truffini & Regge Farmaceutici | Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa |
US20080070875A1 (en) * | 2006-09-11 | 2008-03-20 | Majewski George P | Acne treatment compositions and methods of use |
IT1393841B1 (it) | 2009-04-30 | 2012-05-11 | Giuliani Spa | Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi |
AU2010314956A1 (en) * | 2009-11-06 | 2012-04-12 | Alcon Research, Ltd. | Nutritional supplements for relief of dry eye |
-
2015
- 2015-09-21 PL PL15791737.8T patent/PL3197556T3/pl unknown
- 2015-09-21 CA CA2958174A patent/CA2958174C/en active Active
- 2015-09-21 ES ES15791737T patent/ES2968372T3/es active Active
- 2015-09-21 RS RS20240050A patent/RS65173B1/sr unknown
- 2015-09-21 DK DK15791737.8T patent/DK3197556T3/da active
- 2015-09-21 US US15/504,117 patent/US10143715B2/en active Active
- 2015-09-21 FI FIEP15791737.8T patent/FI3197556T3/fi active
- 2015-09-21 HR HRP20240090TT patent/HRP20240090T1/hr unknown
- 2015-09-21 EP EP15791737.8A patent/EP3197556B1/en active Active
- 2015-09-21 PT PT157917378T patent/PT3197556T/pt unknown
- 2015-09-21 WO PCT/IB2015/057267 patent/WO2016046728A1/en active Application Filing
- 2015-09-21 MX MX2017003360A patent/MX2017003360A/es unknown
- 2015-09-21 SM SM20240084T patent/SMT202400084T1/it unknown
- 2015-09-21 SI SI201531984T patent/SI3197556T1/sl unknown
-
2018
- 2018-06-26 US US16/018,381 patent/US10238707B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10143715B2 (en) | 2018-12-04 |
EP3197556B1 (en) | 2023-11-01 |
ES2968372T3 (es) | 2024-05-09 |
PL3197556T3 (pl) | 2024-04-15 |
PT3197556T (pt) | 2024-01-16 |
RS65173B1 (sr) | 2024-03-29 |
CA2958174A1 (en) | 2016-03-31 |
SI3197556T1 (sl) | 2024-03-29 |
WO2016046728A1 (en) | 2016-03-31 |
FI3197556T3 (fi) | 2024-01-19 |
EP3197556A1 (en) | 2017-08-02 |
US10238707B2 (en) | 2019-03-26 |
US20170258864A1 (en) | 2017-09-14 |
SMT202400084T1 (it) | 2024-03-13 |
CA2958174C (en) | 2023-08-15 |
US20180296621A1 (en) | 2018-10-18 |
HRP20240090T1 (hr) | 2024-04-26 |
MX2017003360A (es) | 2017-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3149019T3 (da) | Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme | |
DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
DK3227675T3 (da) | Activin-actrii-antagonister og anvendelser til behandling af myelodysplastisk syndrom | |
DK3119797T3 (da) | Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose | |
DK3212208T3 (da) | Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet | |
DK3096798T3 (da) | Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem | |
DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
DK3018183T3 (da) | Halogenolefinbaseret sammensætning og anvendelse deraf | |
DK3277270T3 (da) | Sammensætninger og fremgangsmåder til behandling af anæmi | |
DK3102555T3 (da) | Sammensætninger af forbindelser og anvendelser deraf | |
DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
DK3366307T3 (da) | Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri | |
DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
DK3194564T3 (da) | Trichodermasammensætninger og anvendelsesfremgangsmåder | |
DK3307299T3 (da) | Kombinationssammensætninger til behandling af lidelser krævende fjernelse eller ødelæggelse af uønskede celleformeringer | |
DK3217963T3 (da) | Fremgangsmåder til behandling af individer med prader-willis syndrom eller smith-magenis syndrom | |
DK3310190T3 (da) | Sammensætning til behandling af kød og anvendelse af denne | |
DK3191103T3 (da) | Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner | |
DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
DK3200748T3 (da) | Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted | |
DK3326635T3 (da) | Behandling og forebyggelse af forkølelse ved hjælp af povidon-iod | |
DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
DK3129378T3 (da) | Bromdomæne-hæmmende forbindelser og farmaceutisk sammensætning omfattende disse til forebyggelse eller behandling af en cancer | |
DK3122743T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme |